Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interactive Brokers Chairman discusses the company's Q2 earnings beat.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thomas Peterffy, founder and chairman of Interactive Brokers
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Kathleen Skarvan, CEO, Electromed Inc
00:10:00
invest in startups solving for Climate Health and Economic Opportunity|Consuelo Valverde,Managing Partner,SV Latam Capital
00:10:00
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide|Alexis Houssou,Managing Partner,HCVC
00:10:00
Challenges and Disparities in New Zealand's Aged Care System Prompt Concerns Over Future Accessibility and Quality of Care|Jeremy Nicoll, CEO, Arvida Group Ltd.
00:10:00
Addressing the Gender Pay Gap in Financial Services with Drs. Tharp, Lurtz, & Mielitz | Daniel Yerger - President of MY Wealth Planners
00:10:00
Peter Robinson Reflects on Fuad Ajami’s Legacy and Middle Eastern Politics
00:10:00
PNC CEO Discusses Strategic BlackRock Sale and Future Financial Plans Amid Economic Uncertainty | Bill Demchak, CEO, PNC Financial Services .
00:10:00
Goliath Mining CEO Discusses Growth Prospects and Exploration Successes at London Conference
00:10:00
Edward R. Collins - Visionary Leader and Principal at Artisan Wealth Management, LLC
00:10:00
CRAFTING A SUSTAINABLE LEGACY ON THE COAST OF BRITISH COLUMBIA | STEVEN HOFER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, WESTERN FOREST PRODUCTS INC
00:10:00
Panel Discussion: Maintaining a Diverse Leadership Pipeline | Tom Monahan - Chief Executive Officer of Heidrick & Struggles
00:10:00
BioLargo's CEO Dennis Calvert Highlights Major Growth Catalysts for the Company | Dennis Calvert , CEO, BioLargo Inc.